Skip to content

Study · Animal study (in vivo) · mouse · 1990

1 result

Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice.

Onodera T, Awaya A

Immunology1 Dec 1990Cited by 21 (Europe PMC)

PMID2177724 (opens in a new tab)PepBankPUB-02177724

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In infected BALB/c mice, synthetic serum thymic factor suppressed thyroid autoantibody production.

    In plain wordsIn mice infected with reovirus, serum thymic factor reduced thyroid autoantibody production.

    Outcome
    DecreaseThyroid autoantibody production
    Study

    mousen: not reported in source

    BALB/c mice infected with reovirus Type 1
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Synthetic serum thymic factor (FTS) suppressed autoantibody production to the thyroid after reovirus Type 1 infection.
    1 context sentence
    Summary · context
    BALB/c mice that are infected with reovirus Type 1 develop thyroiditis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.